United Therapeutics (UTHR) Net Margin (2009 - 2026)
United Therapeutics (UTHR) posted Net Margin of 35.18% for Q1 2026, down 23.7% sequentially from 46.1% in Q4 2025, and down 538.0% YoY from 8.03% in Q1 2025.
United Therapeutics (UTHR) Net Margin (2009 - 2026) Analysis & Trends
United Therapeutics has reported Net Margin for 18 years, with the latest figure at 35.18% in Q1 2026.
- Quarterly Net Margin fell 538.0% year-over-year to 35.18% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 40.61% (up 18.0% YoY) and the FY2025 annual result came in at 41.94%, up 40.0% from the prior year.
- Net Margin retreated to 35.18% in Q1 2026 per UTHR's latest filing, from 46.1% in the prior quarter.
- Over five years, Net Margin peaked at 51.94% in Q1 2022 and troughed at 24.84% in Q2 2022.
- A 5-year average of 40.56% and a median of 41.27% in 2024 frame the typical range for Net Margin.
- The widest YoY moves for Net Margin: up 4447 bps in 2022, down 1381 bps in 2022.
- Over 5 years, Net Margin stood at 26.88% in 2022, then jumped by 31 bps to 35.32% in 2023, then grew by 16 bps to 40.94% in 2024, then climbed by 13 bps to 46.1% in 2025, then declined by 24 bps to 35.18% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 35.18%, 46.1%, and 42.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.51% |
| Mar 31, 2026 | 35.18% |
| Dec 31, 2025 | 46.10% |
| Sep 30, 2025 | 42.36% |
| Jun 30, 2025 | 38.76% |
| Mar 31, 2025 | 40.56% |
| Dec 31, 2024 | 40.94% |
| Sep 30, 2024 | 41.27% |
| Jun 30, 2024 | 38.90% |
| Mar 31, 2024 | 45.24% |
| Dec 31, 2023 | 35.32% |
| Sep 30, 2023 | 43.91% |
| Jun 30, 2023 | 43.45% |
| Mar 31, 2023 | 47.52% |
| Dec 31, 2022 | 26.88% |
| Sep 30, 2022 | 46.38% |
| Jun 30, 2022 | 24.84% |
| Mar 31, 2022 | 51.94% |
| Dec 31, 2021 | 27.02% |
| Sep 30, 2021 | 36.59% |